Publications by authors named "Ramon Esbri"

Claim this Profile
A
A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Rosa M Antonijoan, Consuelo García-Gea, Montserrat Puntes, Marta Valle, Ramon Esbri

Clin Drug Investig· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
Marta Robert, Miquel Salvà, Rosa Segarra, Marco Pavesi, Ramón Esbri

Drug Metab Dispos· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Rosa Antonijoan, Consuelo García-Gea, Montserrat Puntes, Joselin Pérez, Ramón Esbrí

Clin Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
Paul Ratner, Meritxell Falqués, Ferran Chuecos, Ramon Esbrí, Juan Gispert

Int Arch Allergy Immunol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
Juan Gispert, Rosa Antonijoan, Manel Barbanoj, Ignaci Gich, Estrella Garcia

Ann Allergy Asthma Immunol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis